Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA.
Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.
Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.
Location: Spain, Catalonia, Barcelona
Employees: 11-50
Founded date: 2021
Investors 1
| Date | Name | Website |
| 03.10.2021 | Asabys Par... | asabys.com... |
Mentions in press and media 5
| Date | Title | Description |
| 26.07.2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| 21.06.2023 | Nuage Therapeutics cierra una ronda Seed de €12M liderada por Sofinnova Partners y Asabys. Participan CDTI y BStartup | 21/06/2023 Nota de prensa NUAGE THERAPEUTICS CIERRA UNA RONDA SEED DE €12M LIDERADA POR SOFINNOVA PARTNERS Y ASABYS. PARTICIPAN CDTI Y BSTARTUP Nuage Therapeutics (“Nuage”), compañía biotecnológica que desarrolla un motor de descubrimien... |
| 10.05.2022 | Nuage Therapeutics, participada por Asabys Partners, incorpora a Judit Anido como Consejera Delegada | 10/05/2022 Nota de prensa NUAGE THERAPEUTICS INCORPORA A LA EMPRENDEDORA Y EJECUTIVA JUDIT ANIDO COMO CONSEJERA DELEGADA. • Judit Anido se une a Nuage Therapeutics como co-fundadora y CEO (Chief Executive Officer) y pasa a ser miembro de... |
| 28.09.2021 | Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys | Nuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its work discovering drugs aimed at therapeutic... |
| 28.09.2021 | Nuage Therapeutics secures a round backed by Asabys Partners | 28/09/2021 Press release NUAGE THERAPEUTICS, THE SPIN-OFF FROM IRB BARCELONA AND ICREA, IS LAUNCHED WITH THE SUPPORT OF ASABYS. • Nuage Therapeutics is a spin-off of IRB Barcelona and ICREA and was founded by the researchers Xavier Salva... |